BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8813458)

  • 1. Somatostatin receptor manipulation.
    Visser-Wisselaar HA; Hofland LJ; van Uffelen CJ; van Koetsveld PM; Lamberts SW
    Digestion; 1996; 57 Suppl 1():7-10. PubMed ID: 8813458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17-beta-estradiol-dependent regulation of somatostatin receptor subtype expression in the 7315b prolactin secreting rat pituitary tumor in vitro and in vivo.
    Visser-Wisselaar HA; Van Uffelen CJ; Van Koetsveld PM; Lichtenauer-Kaligis EG; Waaijers AM; Uitterlinden P; Mooy DM; Lamberts SW; Hofland LJ
    Endocrinology; 1997 Mar; 138(3):1180-9. PubMed ID: 9048625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
    Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 17beta-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures.
    Djordjijevic D; Zhang J; Priam M; Viollet C; Gourdji D; Kordon C; Epelbaum J
    Endocrinology; 1998 May; 139(5):2272-7. PubMed ID: 9564833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Internalisation of isotope-coupled somatostatin analogues.
    Hofland LJ; van Koetsveld PM; Waaijers M; Lamberts SW
    Digestion; 1996; 57 Suppl 1():2-6. PubMed ID: 8813457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors.
    Hofland LJ; De Herder WW; Visser-Wisselaar HA; Van Uffelen C; Waaijers M; Zuyderwijk J; Uitterlinden P; Kros MJ; Van Koetsveld PM; Lamberts SW
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3011-8. PubMed ID: 9284735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours.
    Hubina E; Nanzer AM; Hanson MR; Ciccarelli E; Losa M; Gaia D; Papotti M; Terreni MR; Khalaf S; Jordan S; Czirják S; Hanzély Z; Nagy GM; Góth MI; Grossman AB; Korbonits M
    Eur J Endocrinol; 2006 Aug; 155(2):371-9. PubMed ID: 16868153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary somatostatin receptor (sst)1-5 expression during rat development: age-dependent expression of sst2.
    Reed DK; Korytko AI; Hipkin RW; Wehrenberg WB; Schonbrunn A; Cuttler L
    Endocrinology; 1999 Oct; 140(10):4739-44. PubMed ID: 10499533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells.
    Hofland LJ; van Koetsveld PM; Wouters N; Waaijers M; Reubi JC; Lamberts SW
    Endocrinology; 1992 Aug; 131(2):571-7. PubMed ID: 1322274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study.
    Bertherat J; Tenenbaum F; Perlemoine K; Videau C; Alberini JL; Richard B; Dousset B; Bertagna X; Epelbaum J
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5353-60. PubMed ID: 14602773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A luteinizing hormone-, alpha-subunit- and prolactin-secreting pituitary adenoma responsive to somatostatin analogs: in vivo and in vitro studies.
    Saveanu A; Morange-Ramos I; Gunz G; Dufour H; Enjalbert A; Jaquet P
    Eur J Endocrinol; 2001 Jul; 145(1):35-41. PubMed ID: 11415850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor subtype expression in cells of the rat immune system during adjuvant arthritis.
    ten Bokum AM; Lichtenauer-Kaligis EG; Melief MJ; van Koetsveld PM; Bruns C; van Hagen PM; Hofland LJ; Lamberts SW; Hazenberg MP
    J Endocrinol; 1999 Apr; 161(1):167-75. PubMed ID: 10194540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro.
    Pawlikowski M; Lawnicka H; Pisarek H; Kunert-Radek J; Radek M; Culler MD
    J Physiol Pharmacol; 2007 Mar; 58(1):179-88. PubMed ID: 17440235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin-induced control of cytosolic free calcium in pituitary tumour cells.
    Petrucci C; Cervia D; Buzzi M; Biondi C; Bagnoli P
    Br J Pharmacol; 2000 Feb; 129(3):471-84. PubMed ID: 10711345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptors in pituitary function, diagnosis and therapy.
    Hofland LJ; Lamberts SW
    Front Horm Res; 2004; 32():235-52. PubMed ID: 15281350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours.
    de Herder WW; Hofland LJ; van der Lely AJ; Lamberts SW
    Endocr Relat Cancer; 2003 Dec; 10(4):451-8. PubMed ID: 14713257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.
    Capello A; Krenning E; Bernard B; Reubi JC; Breeman W; de Jong M
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1288-95. PubMed ID: 16021448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptor sst2 gene transfer in human prolactinomas in vitro: impact on sensitivity to dopamine, somatostatin and dopastatin, in the control of prolactin secretion.
    Cuny T; Mohamed A; Graillon T; Roche C; Defilles C; Germanetti AL; Couderc B; Figarella-Branger D; Enjalbert A; Barlier A; Saveanu A
    Mol Cell Endocrinol; 2012 May; 355(1):106-13. PubMed ID: 22348806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.
    Hofland LJ; van der Hoek J; Feelders R; van Aken MO; van Koetsveld PM; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; de Herder WW; Beckers A; Lamberts SW
    Eur J Endocrinol; 2005 Apr; 152(4):645-54. PubMed ID: 15817922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative and functional expression of somatostatin receptor subtypes in human prolactinomas.
    Jaquet P; Ouafik L; Saveanu A; Gunz G; Fina F; Dufour H; Culler MD; Moreau JP; Enjalbert A
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3268-76. PubMed ID: 10487698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.